Against Naltrexone/Bupropion, observed associations with reduced incidence emerged for cataracts (HR 0.37, 95% CI: 0.180.75, p = 0.004), oculomotor binocular dysfunction (HR 0.46, 95% CI: 0.270.79, p = 0.004), dry eye disease (HR 0.36, 95% CI: 0.180.73, p = 0.003), and ametropic accommodative dysfunction (HR 0.50, 95% CI: 0.290.87, p = 0.012)
- Haemoglobin (HGB)
While numerous other GLP1 receptor agonists have since been developed for the management of diabetes, it wasnt until 2014 that a GLP1 receptor agonist, Saxenda (liraglutide), was approved for obesity (liraglutide had previously been approved for diabetes under the name Victoza)
Jeong EM, Yoon J-H, Lim J, Shin J-W, Cho AY, Heo J, Lee KB, Lee J-H, Lee WJ, Kim H-J, Son YH, Lee S-J, Cho S-Y, Shin D-M, Choi K, Kim I-G
The test mouse explored the chambers for 10 min
PPI Inhibitors Esomeprazole (Nexium) Lansoprazole (Prevacid) Omeprazole (Prilosec) Dexlansoprazole (Dexilant) Pantoprazole (Protonix) Rabeprazole (AcipHex) H2 Blockers Examples include: Cimetidine (Tagamet) Famotidine (Pepcid) Nizatidine (Axid) Chemotherapy Medications Consider the following: Taxanes This class of chemotherapy drugs, including paclitaxel (Taxol) and docetaxel (Taxotere), disrupts cell division, which may cause issues with the meibomian gland and obstruct the channels through which tears flow
